As a global leader in the pharmaceutical supply chain, NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to providing high-quality chemical intermediates that drive advancements in healthcare. Among our portfolio, Doxofylline stands out as a critical compound for managing severe respiratory conditions like asthma and Chronic Obstructive Pulmonary Disease (COPD). This article delves into the intricacies of Doxofylline, examining its therapeutic benefits, its mechanism of action, and why it represents a significant step forward in respiratory pharmacotherapy.

Doxofylline, identified by its CAS number 69975-86-6, is a xanthine derivative. Its primary function is to act as a bronchodilator and possess anti-inflammatory properties. Unlike its predecessors, such as theophylline, Doxofylline has been developed with an improved therapeutic window. This means it can achieve significant therapeutic effects with a reduced incidence of adverse reactions, particularly cardiovascular and gastrointestinal disturbances. This enhanced safety profile is a key reason why healthcare professionals are increasingly considering Doxofylline for their patients.

The efficacy of Doxofylline in managing respiratory diseases stems from its unique mechanism of action. It functions by inhibiting phosphodiesterase (PDE) enzymes, specifically PDE-IV. By inhibiting these enzymes, Doxofylline increases the levels of cyclic adenosine monophosphate (cAMP) within cells. Elevated cAMP levels lead to smooth muscle relaxation in the airways, resulting in bronchodilation and facilitating easier breathing. Furthermore, the anti-inflammatory properties of Doxofylline contribute to reducing airway inflammation, a common characteristic of asthma and COPD.

One of the most compelling aspects of Doxofylline is its significantly lower affinity for adenosine receptors compared to theophylline. Theophylline's interaction with these receptors is often linked to its undesirable side effects, including cardiac arrhythmias and central nervous system stimulation. By largely avoiding these interactions, Doxofylline offers a safer profile, making it a more suitable option for long-term management of chronic respiratory conditions. Patients seeking to buy Doxofylline can trust NINGBO INNO PHARMCHEM CO.,LTD. for pharmaceutical-grade products.

The practical application of Doxofylline in clinical settings is extensive. It is prescribed for patients suffering from bronchial asthma, chronic obstructive pulmonary disease (COPD), and chronic bronchitis. The drug can be administered orally in various forms, including tablets and syrups, with dosages typically ranging up to 1,200 mg daily. For more acute situations, slow intravenous injection is also an option under medical supervision. The rapid onset of action is another advantage, providing swift relief from bronchospastic symptoms.

When considering Doxofylline price, it is essential to focus on the value it brings in terms of therapeutic efficacy and patient safety. NINGBO INNO PHARMCHEM CO.,LTD. ensures competitive pricing for its high-quality Doxofylline, making this advanced treatment accessible. Understanding the Doxofylline uses is crucial for both healthcare providers and patients. It is a testament to pharmaceutical innovation, offering a better alternative for individuals struggling with breathing difficulties.

For those seeking to source this vital compound, NINGBO INNO PHARMCHEM CO.,LTD. is a reliable Doxofylline supplier. We are committed to maintaining the highest standards of quality and purity, ensuring that our Doxofylline meets the rigorous demands of the pharmaceutical industry. By choosing NINGBO INNO PHARMCHEM CO.,LTD., you are partnering with a company dedicated to improving global health outcomes through advanced chemical solutions.